The evidence

Built on highest quality science.

Award-winning science published in a top international journal. Validated in 1200+ patients, patents pending.

  1. Tumour core in multiplex immunofluorescence, magenta epithelium threaded with green stroma
  2. Tumour core in multiplex immunofluorescence, blue nuclei with white epithelial islands
  3. Tumour core in multiplex immunofluorescence, amber and magenta tumour nests in a green stromal mesh
Three tumours from the same cohort, imaged with multiplex immunofluorescence: three different spatial ecosystems.

Scientific papers.

  1. First page of the preprint Colorectal cancer heterogeneity co-evolves with tumor architecture to determine disease outcome bioRxiv preprint · August 2025 Colorectal cancer heterogeneity co-evolves with tumor architecture to determine disease outcome Fabien Bertillot, Solène Hervé, Nelly Drobjazko et al.
  2. First page of the article Multiparameter imaging reveals clinically relevant cancer cell-stroma interaction dynamics in head and neck cancer, Cell 2024 Cell 187, 7267–7284 · October 2024 Minerva Medix Prize 2025 Multiparameter imaging reveals clinically relevant cancer cell-stroma interaction dynamics in head and neck cancer Karolina Punovuori, Fabien Bertillot, Yekaterina A. Miroshnikova et al.
"Spatial diagnostics is where genomics was ten years ago. Genomic profiling sat in research until the assay became routine and the guidelines followed. The difference is that we don't need a new instrument in the lab for it to happen."
Michael Wittinger, PhD, CEO
  • PublishedProof of concept in 650 head-and-neck cancer patients, Cell, 2024, awarded Minerva Medix Prize for top biomedical study in Finland in 2025. Follow-on indication under review.
  • RecognisedSpun out from the lab of co-founder Sara Wickström, Körber European Science Prize 2026. Research Director, Max Planck Institute and University of Helsinki.
  • ConnectedIntegrated with US and EU digital pathology platforms. Collaborations with University of Helsinki and UKE Hamburg-Eppendorf. Member of Health Incubator Helsinki. NVIDIA Inception program, Spark Finland alumni.
  • ProtectedThree pending patents.

Bring us your dataset, or your biomarker.

The Decode early release is free to test. Thirty minutes is enough to get you set up, or to see whether your discovery has a route to the clinic.

Book a demo